Acquisition strengthens Onyx’s ability to help health plans modernize ePA, scale to meet CMS deadlines, and maximize ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Licensed scientific and clinical intelligence integrated into the 3RnD platform to support AI-Driven Discovery and ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: New Data: “Admission-First” AI ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...
Their solution, VetEvince, went beyond simple automation or AI chat assistants. It promised to deliver insights anchored in ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...
When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...
Quality data is critical to informing public health actions. | The time has come for CMS to implement performance measures—or quantitative metrics—for public health and clinical data exchange, writes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results